growing investment in drug discovery is driving the Clinical Trial Imaging Market

Latest News:- Clinical Trial Imaging Market: Computed tomography is expected to lead the Modality segment during 2024-2028

Technavio analyzes that the Clinical Trial Imaging Market is expected to grow at a CAGR of 7.5% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 551.3 million.There are various factors that contribute to the growth of the market. The clinical trial imaging market is experiencing significant growth due to increasing investments in drug discovery and development. This trend is driven by the advancement of imaging technologies, which enable more accurate and efficient diagnosis and monitoring of diseases. Pharmaceutical companies and research institutions are allocating substantial resources towards clinical trials utilizing imaging techniques, contributing to the market's expansion. The integration of imaging biomarkers into clinical trials is also facilitating personalized medicine approaches, further fueling market growth.

The clinical trial imaging market is experiencing notable growth, with a particular focus on Computed Tomography (CT) technology. CT imaging is a vital modality in clinical trials due to its ability to generate precise, cross-sectional images of the body, enabling accurate diagnosis and monitoring of conditions like cancer. With the rising prevalence of chronic diseases and the demand for early and precise diagnosis, there is an increasing reliance on advanced imaging technologies. CT imaging's capacity to provide comprehensive anatomical information is indispensable for assessing disease progression and evaluating treatment efficacy in clinical trials. Furthermore, technological innovations in CT imaging, such as Photon Counting Computed Tomography (PCCT), are expanding the capabilities of clinical trial imaging, offering enhanced diagnostic accuracy and improved patient comfort. 

Know which region is leading the market growth by requesting a sample report

Clinical Trial Imaging Market Segmentation

• Modality
  • Computed tomography
  • Magnetic resonance imaging
  • Ultrasound
  • Positron emission tomography
  • Others
• End-user
  • Contract research organization
  • Pharmaceutical and biotechnology companies
  • Research and academic institutes
  • Medical device manufacturers
• Geography
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

Top Performing Companies

As per our research findings, here are some of the key competitors that are leading the industry

• Alimentiv Inc
• ARANZ Medical Ltd
• Aster Medical Imaging LLC
• Charles River Laboratories International Inc.
• Clario
• ICON plc
• Image Core Lab Pvt Ltd
• IXICO plc
• Median Technologies SA
• Medidata
• Medpace Holdings Inc.
• Navitas Life Sciences
• Octalsoft
• QMENTA Imaging SL
• QUANTIFICARE
• THIRONA
• Vista Diagnostics Ltd
• Voiant
• WCG Clinical Inc.
• Yunu, Inc.

Find out what is trending in the market by accessing the free PDF report

Research Analysis Overview

The Clinical Trial Imaging Market encompasses the use of Medical Imaging in Biotechnology and Pharmaceutical sectors for Clinical Trials. Imaging Technologies, including CT, MRI, Echocardiography, Nuclear Medicine, PET, X-ray, Ultrasound, Optical Coherence Tomography, and Virtual Imaging Trials, employ Image Analysis Software and Artificial Intelligence/Machine Learning for improved diagnostic accuracy. Imaging Modalities find application in various therapeutic areas like Oncology, Neurology, Endocrinology, and Cardiology. Medical Devices and therapeutic expertise are also integral to this market.

Market Research Overview

The Clinical Trial Imaging Market encompasses the earnings from the sale of medical imaging equipment, IT systems, internet-based healthcare tools, telehealth technologies, digital health technologies, and IT consulting services to healthcare providers and businesses. According to Technavio, the global healthcare market size is determined by the consolidated revenue generated by manufacturers and providers of medical devices, pharmaceuticals, biotechnology, healthcare technology firms, and life sciences tools and services. The expansion of the healthcare technology market is influenced by factors affecting both the healthcare industry and IT spending market. Key drivers include the continuous need to decrease costs, which is a significant challenge for healthcare organizations in both developed and emerging economies.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Reasons to Consider Purchasing Technavio Market Research Report

• Current Market Insights: Our reports offer valuable information on the latest market intelligence, competitor strategies, trends, industry changes, customer preferences, and forecasted market opportunities to aid in informed business decisions.


• Extensive Experience: With over 20 years in market research, Technavio is a trusted name, having published more than 21,000 reports across various industries and regions.


• High ROI Through In-Depth Research: Technavio specializes in tailored market research reports to meet specific business needs, exploring particular markets, product segments, and demographics. We are also recognized for delivering significant returns on investment through our comprehensive data collection at affordable prices.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/